Alnylam Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
CEOYvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees2,100
Employees2,100
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2002
Founded2002
Employees2,100
Employees2,100
ALNY Key Statistics
Market cap18.95B
Market cap18.95B
Price-Earnings ratio-42.09
Price-Earnings ratio-42.09
Dividend yield—
Dividend yield—
Average volume506.10K
Average volume506.10K
High today$151.95
High today$151.95
Low today$143.95
Low today$143.95
Open price$144.21
Open price$144.21
Volume735.87K
Volume735.87K
52 Week high$218.88
52 Week high$218.88
52 Week low$141.98
52 Week low$141.98
ALNY News
Yahoo Finance 2d
Gear Up for Alnylam Q1 Earnings: Wall Street Estimates for Key Metrics - Yahoo FinanceAnalysts on Wall Street project that Alnylam Pharmaceuticals (ALNY) will announce quarterly loss of $0.75 per share in its forthcoming report, representing an i...
TipRanks 2d
Alnylam, Medison Pharma expand partnershipMedison Pharma and Alnylam Pharmaceuticals announced a further expansion of their existing partnership in Central & Eastern Europe and Israel, to also include s...
Yahoo Finance 2d
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe ... - Yahoo FinanceThe expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance Medison, the creat...
Analyst ratings
70%
of 30 ratingsBuy
70%
Hold
30%
Sell
0%
More ALNY News
Yahoo Finance 7d
Alnylam Pharmaceuticals Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo FinanceWall Street expects a year-over-year increase in earnings on higher revenues when Alnylam Pharmaceuticals (ALNY) reports results for the quarter ended March 202...
